544
Views
85
CrossRef citations to date
0
Altmetric
Review

Olive polyphenols: new promising agents to combat aging-associated neurodegeneration

&
Pages 345-358 | Received 10 Jun 2016, Accepted 04 Oct 2016, Published online: 20 Oct 2016

References

  • Rigacci S, Guidotti V, Bucciantini M, et al. Aβ(1-42) aggregates into non-toxic amyloid assemblies in the presence of the natural polyphenol oleuropein aglycon. Curr Alz Res. 2011;8:84152.
  • Daccache A, Lion C, Sibille N, et al. Oleuropein and derivatives from olives as Tau aggregation inhibitors. Neurochem Int. 2011;58:700–707.
  • Caruana M, Högen T, Levin J, et al. Inhibition and disaggregation of α-synuclein oligomers by natural polyphenolic compounds. FEBS Lett. 2011;585:1113–1120.
  • Ladiwala AR, Dordick JS, Tessler PM. Aromatic small molecules remodel toxic soluble oligomers of amyloid β through three independent pathways. J Biol Chem. 2011;286:3209–3218.
  • Cheng B, Gong H, Xiao H, et al. Inhibiting toxic aggregation of amyloidogenic proteins: a therapeutic strategy for protein misfolding diseases. Biochim Biophys Acta. 2013;1830:4860–4871.
  • Ahmad E, Ahmad A, Singh S, et al. A mechanistic approach for islet amyloid polypeptide aggregation to develop anti-amyloidogenic agents for type-2 diabetes. Biochimie. 2011;93:793–805.
  • Wu C, Lei H, Wang Z, et al. Phenol red interacts with the protofibril-like oligomers of an amyloidogenic hexapeptide NFGAIL through both hydrophobic and aromatic contacts. Biophys J. 2006;91:3664–3672.
  • Féart C, Samieri C, Allès B, et al. Potential benefits of adherence to the Mediterranean diet on cognitive health. Proc Nutr Soc. 2013;72:140–152.
  • Scarmeas N, Stern Y, Mayeux R, et al. Mediterranean diet and mild cognitive impairment. Arch Neurol. 2009;66:216–225.
  • Pitozzi V, Jacomelli M, Catelan D, et al. Long-term dietary extra-virgin olive oil rich in polyphenols reverses age-related dysfunctions in motor coordination and contextual memory in mice: role of oxidative stress. Rejuvenation Res. 2012;15:601–612.
  • López-Miranda J, Pérez-Jiménez F, Ros E, et al. Olive oil and health: summary of the II international conference on olive oil and health consensus report, Jaén and Córdoba (Spain) 2008. Nutr Metab Cardiovasc Dis. 2010;20:284–294.
  • Qosa H, Mohamed LA, Batarseh YS, et al. Extra-virgin olive oil attenuates amyloid-β and tau pathologies in the brains of TgSwDI mice. J Nutr Biochem. 2015;26:1479–1490.
  • Abuznait AH, Qosa H, Busnena BA, et al. Olive-oil-derived oleocanthal enhances βamyloid clearance as a potential neuroprotective mechanism against Alzheimer’s disease: in vitro and in vivo studies. ACS Chem Neurosci. 2013;4:973–982.
  • Grossi C, Rigacci S, Ambrosini S, et al. The polyphenol oleuropein aglycone protects TgCRND8 mice against Aβ plaque pathology. PLoS One. 2013;8:e71762.
  • Monti MC, Margarucci L, Riccio R, et al. Modulation of tau protein fibrillization by oleocanthal. J Nat Prod. 2012;75:1584–1588.
  • Bach FA, Berry EM, Lairon D, et al. Mediterranean diet pyramid today. Science and cultural updates. Mediterranean diet foundation expert group. Public Health Nutr. 2011;14(12A):2274–2284.
  • Williams RJ, Spencer JP, Rice-Evans C. Flavonoids: antioxidants or signalling molecules?. Free Rad Biol Med. 2004;36:838–849.
  • Halliwell B. Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment. Drugs Aging. 2001;18:685–716.
  • Stefani M, Rigacci S. Beneficial properties of natural phenols: highlight on protection against pathological conditions associated with amyloid aggregation. BioFactors 2014;40:482–493.
  • Ayissi VB, Ebrahimi A, Schluesenner H. Epigenetic effects of natural polyphenols: a focus on SIRT1-mediated mechanisms. Mol Nutr Food Res. 2014;58:22–32.
  • Vissers MN, Zock PL, Katan MB. Bioavailability and antioxidant effects of olive oil phenols in humans: a review. Eur J Clin Nutr. 2004;58:955–965.
  • Cicerale S, Lucas L, Keast R. Biological activities of phenolic compounds present in virgin olive oil. Int J Mol Sci. 2010;11:458–479.
  • Tripoli E, Giammanco M, Tabacchi G, et al. The phenolic compounds of olive oil: structure, biological activity and beneficial effects on human health. Nutr Res Rev. 2005;18:98–112.
  • Menotti A, Puddu PE. Coronary heart disease differences across Europe: a contribution from the Seven Countries Study. J Cardiovasc Med (Hagerstown). 2013;14:767–772.
  • Berr C, Portet F, Carriere I, et al. Olive oil and cognition: results from the Three-city study. Dement Geriatr Cogn Disord. 2009;28:357–364.
  • Covas MI. Bioactive effects of olive oil phenolic compounds in humans: reduction of heart disease factors and oxidative damage. Inflammopharmacology. 2008;16:216–218.
  • Psaltopoulou T, Kosti RI, Haidopoulos D, et al. Olive oil intake is inversely related to cancer prevalence: a systematic review and a meta-analysis of 13,800 patients and 23,340 controls in 19 observational studies. Lipids Health Dis. 2011;10:127.
  • Rigacci S, Stefani M. Nutraceuticals and amyloid neurodegenerative diseases: a focus on natural phenols. Exp Rev Neurother. 2014;15:41–52.
  • Dinda B, Debnath S, Banik R. Naturally occurring iridoids and secoiridoids. An updated review, part 4. Chem Pharm Bull (Tokyo). 2011;59:803–833.
  • Karkoula E, Skantzari A, Melliou E, et al. Direct measurement of oleocanthal and oleacein levels in olive oil by quantitative (1)H NMR. Establishment of a new index for the characterization of extra virgin olive oils. J Agric Food Chem. 2012;60:11696–11703.
  • Fabiani R, Rosignoli P, De Bartolomeo A, et al. Oxidative DNA damage is prevented by extracts of olive oil, hydroxytyrosol, and other olive phenolic compounds in human blood mononuclear cells and HL60 cells. J Nutr. 2008;138:1411–1416.
  • Tundis R, Loizzo M, Menichini F, et al. Biological and pharmacological activities of iridoids: recent developments. Mini Rev Med Chem. 2008;8:399–420.
  • Ranalli A, Marchegiani D, Contento S, et al. Variations of iridoid oleuropein in Italian olive varieties during growth and maturation. Eur J Lipid Sci Technol. 2009;111:678–687.
  • Servili M, Montedoro GF. Contribution of phenolic compounds in virgin olive oil quality. Eur J Lipid Sci Technol. 2002;104:602–613.
  • Selkoe DJ. Folding proteins in fatal ways. Nature. 2003;426:900–904.
  • Stefani M. Structural features and cytotoxicity of amyloid oligomers: implications in Alzheimer’s disease and other diseases with amyloid deposits. Progress Neurobiol. 2012;99:226–245.
  • Rigacci S, Guidotti V, Bucciantini M, et al. Oleuropein aglycon prevents cytotoxic amyloid aggregation of human amylin. J Nutr Biochem. 2010;21:726–735.
  • Leri M, Nosi D, Natalello A, et al. The polyphenol Oleuropein aglycone hinders the growth of toxic transthyretin amyloid assemblies. J Nutr Biochem. 2016;30:153–166.
  • Pitt J, Roth W, Lacor P, et al. Alzheimer’s-associated Aβ oligomers show altered structure, immunoreactivity and synaptotoxicity with low doses of oleocanthal. Toxicol Appl Pharmacol. 2009;240:189–197.
  • Galanakis PA, Bazoti FN, Bergquist J, et al. Study of the interaction between the amyloid beta peptide (1-40) and antioxidant compounds by nuclear magnetic resonance spectroscopy. Biopolymers. 2011;96:316–327.
  • Ladiwala AR, Mora-Pale M, Lin JC, et al. Polyphenolic glycosides and aglycones utilize opposing pathways to selectively remodel and inactivate toxic oligomers of amyloid β. ChemBioChem. 2011;12:1749–1758.
  • Kostomoiri M, Fragkouli A, Sagnou M, et al. Oleuropein, an anti-oxidant polyphenol constituent of olive promotes α-secretase cleavage of the amyloid precursor protein (AβPP). Cell Mol Neurobiol. 2013;33:147–154.
  • Monti MC, Margarucci L, Tosco A, et al. New insights on the interaction mechanism between tau protein and oleocanthal, an extra-virgin olive-oil bioactive component. Food Funct. 2011;2:423–428.
  • Cassiano C, Casapullo A, Tosco A, et al. In cell interactome of oleocanthal, an extra virgin olive oil bioactive component. Nat Prod Commun. 2015;10:1013–1016.
  • Margarucci L, Monti MC, Cassiano C, et al. Chemical proteomics-driven discovery of oleocanthal as an Hsp90 inhibitor. Chem Commun (Camb). 2013;49:5844–5846.
  • Rigacci S. Olive oil phenols as promising multi-targeting agents against Alzheimer’s disease. Adv Exp Med Biol. 2015;863:1–20.
  • De Bock M, Derraik JGB, Brennan CM, et al. Olive (Olea europaea L.) leaf polyphenols improve insulin sensitivity in middle-aged overweight men: a randomized, placebo-controlled, crossover trial. PLoS One. 2013;8:e57622.
  • Wainstein J, Ganz T, Boaz M, et al. Olive leaf extract as a hypoglycemic agent in both human diabetic subjects and in rats. J Med Food. 2012;15:605–610.
  • Biessels GJ, Reagan LP. Hippocampal insulin resistance and cognitive dysfunction. NatureRev Neurol. 2015;16:660–671.
  • Bitra VR, Deepthi Rapaka D, Akula A. Prediabetes and Alzheimer’s Disease. Indian J Pharm Sci. 2015;77:511–514.
  • Bedse G, Di Domenico F, Serviddio G, et al. Aberrant insulin signaling in Alzheimer’s disease: current knowledge. Front Neurosci. 2015;9:204.
  • De La Monte SM. Type 3 diabetes in sporadic Alzheimer׳s disease: mini-review. Eur Neuropsychopharmacol. 2014;24:1954–1960.
  • Jolivalt CG, Lee CA, Beiswenger KK, et al. Defective insulin signaling pathway and increased glycogen synthase kinase-3 activity in the brain of diabetic mice: parallels with Alzheimer’s disease and correction by insulin. J Neurosci Res. 2008;86:3265–3274.
  • Rigacci S, Stefani M. Nutraceutical properties of olive oil polyphenols. An itinerary from cultured cells through animal models to humans. Int J Mol Sci. 2016;17:pii:E843.
  • Xu J, Kao S-Y, Lee FJS, et al. Dopamine-dependent neurotoxicity of α-synuclein: a mechanism for selective neurodegeneration in Parkinson’s’s disease. Nat Med. 2002;8:600–606.
  • Burke WJ, Li SW, Williams EA, et al. 3,4-Dihydroxyphenylacetaldehyde is the toxic dopamine metabolite in vivo: implications for Parkinson’s’s disease pathogenesis. Brain Res. 2003;989:205–213.
  • Schaffer S, Podstawa M, Visioli F, et al. Hydroxytyrosol-rich olive mill wastewater extract protects brain cells in vitro and ex vivo. J Agr Food Chem. 2007;55:5043–5049.
  • González-Correa JA, Navas MD, Lopez-Villodres JA, et al. Neuroprotective effect of hydroxytyrosol and hydroxytyrosol acetate in rat brain slices subjected to hypoxia-reoxygenation. Neurosci Lett. 2008;446:143–146.
  • Sarsour EH, Kumar MG, Kalen AL, et al. MnSOD activity regulates hydroxytyrosolinduced extension of chronological lifespan. Age (Dordr). 2012;34:95–109.
  • Canuelo A, Gilbert-Lopez B, Pacheco-Linan P, et al. Tyrosol, a main phenol present in extra virgin olive oil, increases lifespan and stress resistance in Caenorhabditis elegans. Mech Ageing Dev. 2012;133:563–574.
  • Odiatou EM, Skaltsounis AL, Constantinou A. Identification of the factors responsible for the in vivo pro-oxidant and cytotoxic activities of the olive polyphenols oleuropein and hydroxytyrosol. Cancer Lett. 2013;330:113–121.
  • Menendez JA, Joven J, Aragonès G, et al. Xenohormetic and anti-aging activity of secoiridoid polyphenols present in extra virgin olive oil: A new family of gerosuppressant agents. Cell Cycle. 2013;12:555–578.
  • Rigacci S, Miceli C, Nediani C, et al. Oleuropein aglycone induces autophagy via the AMPK/mTOR signalling pathway: a mechanistic insight. Oncotarget. 2015;6:35344–35357.
  • Wang M, Yu T, Zhu C, et al. Resveratrol triggers protective autophagy through the Ceramide/Akt/mTOR pathway in melanoma B16 cells. Nutr Cancer. 2014;66:435–440.
  • St-Laurent-Thibault C, Arseneault M, Longpre F, et al. Tyrosol and hydroxytyrosol two main components of olive oil, Protect N2a cells against amyloid-β-induced toxicity. Involvement of the NF-κB signaling. Curr Alz Res. 2011;8:543–551.
  • Yu G, Deng A, Tang W, et al. Hydroxytyrosol induces phase II detoxifying enzyme expression and effectively protects dopaminergic cells against dopamine- and 6-hydroxydopamine induced cytotoxicity. Neurochem Int. 2016;96:113–120.
  • Galinano V, Villalain J. Oleuropein aglycone in lipid bilayer membranes. A molecular dynamics study. Biochim Biophys Acta. 2015;1848:2849–2858.
  • Peyrot Des Gachons C, Uchida K, Bryant B, et al. Unusual pungency from extra virgin olive oil is attributable to restricted spatial expression of the receptor of oleocanthal. J Neurosci. 2011;31:999–1009.
  • Diomede L, Rigacci S, Romeo M, et al. Oleuropein aglycone protects transgenic C. elegans strains expressing Aβ42 by reducing plaque load and motor deficit. PLoS One. 2013;8:e58893.
  • Chishti MA, Yang DS, Janus C, et al. Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695. J Biol Chem. 2001;276:21562–21570.
  • Luccarini I, Grossi C, Rigacci S, et al. Oleuropein aglycone protects against pyroglutamylated-3 amyloid-β toxicity: biochemical, epigenetic and functional correlates. Neurobiol Aging. 2015;36:648–663.
  • Pantano D, Luccarini I, Nardiello P, et al. Oleuropein aglycone and polyphenols from olive mill wastewater ameliorate cognitive deficits and neuropathology. Br J Clin Pharmacol. 2016. Published on line 2016 Aug 18. DOI:10.1111/bcp.12993
  • Luccarini I, Ed Dami T, Grossi C, et al. Oleuropein aglycone counteracts Aβ42 toxicity in the rat brain. Neurosci Lett. 2014;558:67–72.65.
  • Qosa H, Batarseh YS, Moyeldin MM, et al. Oleocanthal enhances amyloid-β clearance from the brains of TgSwDI mice and in vitro across a human blood-brain barrier model. ACS Chem Neurosci. 2015;6:1849–1859.
  • Arunsundar M, Shanmugarajan TS, Ravichandran V. 3,4-dihydroxyphenylethanol attenuates spatio-cognitive deficits in an Alzheimer’s disease mouse model: modulation of the molecular signals in neuronal survival-apoptotic programs. Neurotox Res. 2015;27:143–155.
  • Remely M, Stefanska B, Lovrecic L, et al. Nutriepigenomics: the role of nutrition in epigenetic control of human diseases. Curr Opin Clin Nutr Metab Care. 2015;18:328–333.
  • Gräff J, Rei D, Guan JS, et al. An epigenetic blockade of cognitive functions in the neurodegenerating brain. Nature. 2012;483:222–226.
  • Adwan L, Zawia NH. Epigenetics: a novel therapeutic approach for the treatment ofAlzheimer’s disease. Pharmacol Ther. 2013;139:41–50.
  • Covas MI, Konstantinidou V, Fitó M. Olive oil and cardiovascular health. J Cardiovasc Pharmacol. 2009;54:477–482.
  • Martínez-Lapiscina EH, Clavero P, Toledo E, et al. Virgin olive oil supplementation and long-term cognition: theMediterranean diet improves cognition: the PREDIMED-NAVARRA randomised trial. J Nutr Health Aging. 2013;17:544–552.
  • Valls-Pedret C, Lamuela-Raventos RM, Medina-Remon A, et al. Polyphenol-rich foods in the Mediterranean diet are associated with better cognitive function in elderly subjects at high cardiovascular risk. J Alz Dis. 2012;29:773–782.
  • Knight A, Bryan J, Wilson C, et al. A randomised controlled intervention trial evaluating the efficacy of a Mediterranean dietary pattern on cognitive function and psychological wellbeing in healthy older adults: the MedLey study. BMC Geriatr. 2015;15:55.
  • Valls-Pedret C, Sala-Vila A, Serra-Mir M, et al. Mediterranean diet and age-related cognitive decline: a randomized clinical trial. JAMA Intern Med. 2015;175:1094–1103.
  • Martínez-Lapiscina EH, Galbete C, Corella D, et al. Genotype patterns at CLU, CR1, PICALM and APOE, cognition and Mediterranean diet: the PREDIMED-NAVARRA trial. Genes Nutr. 2014;9:393.
  • Nemeth K, Plumb GW, Berrin JG, et al. Deglycosylation by small intestinal epithelial cell beta-glucosidases is a critical step in the absorption and metabolism of dietary flavonoid glycosides in humans. Eur J Nutr. 2002;42:29–42.
  • Sang S, Lambert JD, Ho CT, et al. The chemistry and biotransformation of tea constituents. Pharmacol Res. 2011;64:87–99.
  • Wu B, Kulkarmi K, Basu S, et al. First-pass metabolism via UDP-glucuronyltransferase: a barrier to oral bioavailability of phenolics. J Pharm Sci. 2011;100:3655–3681.
  • Manach C, Scalbert A, Morand C, et al. Dietary polyphenols: food sources and bioavailability. Am J Clin Nutr. 2004;79:727–747.
  • Ozdal T, Sela DA, Xiao J, et al. The reciprocal interactions between polyphenols and gut microbiota and effects on bioaccessibility. Nutrients. 2016;8:pii: E78.
  • Dueñas M, Cueva C, Muñoz-González I, et al. Studies on modulation of gut microbiota by wine polyphenols: from isolated cultures to Omic approaches. Antioxidants (Basel). 2015;4:1–21.
  • Etxeberria U, Arias N, Boqué N, et al. Reshaping faecal gut microbiota composition by the intake of trans-resveratrol and quercetin in high-fat sucrose diet-fed rats. J Nutr Biochem. 2015;26:651–660.
  • Dueñas M, Muñoz-González I, Cueva C, et al. A survey of modulation of gut microbiota by dietary polyphenols. Biomed Res Int. 2015;2015:850902.
  • Moreno-Indias I, Sánchez-Alcoholado L, Pérez-Martínez P, et al. Red wine polyphenols modulate fecal microbiota and reduce markers of the metabolic syndrome in obese patients. Food Funct. 2016;7:1775–1787.
  • Roopchand DE, Carmody RN, Kuhn P, et al. Dietary polyphenols promote growth of the gut bacterium akkermansia muciniphila and attenuate high-fat diet-induced metabolic syndrome. Diabetes. 2015;64:2847–2858.
  • Gasperotti M, Passamonti S, Tramer F, et al. Fate of microbial metabolites of dietary polyphenols in rats: is the brain their target destination?. ACS Chem Neurosci. 2015;6:1341–1352.
  • Wang D, Ho L, Faith J, et al. Role of intestinal microbiota in the generation of polyphenolderived phenolic acid mediated attenuation of Alzheimer’s disease β-amyloid oligomerization. Mol Nutr Food Res. 2015;59:1025–1040.
  • Lin P, Qian W, Wang X, et al. The biotransformation of oleuropein in rats. Biomed Chromatogr. 2013;27:1162–1167.
  • Corona G, Tzounis X, Dessì MA, et al. The fate of olive oil polyphenols in the gastrointestinal tract. Implications of gastric and colonic microflora-dependent biotransformation. Free Rad Res. 2006;40:647–658.
  • Martín-Peláez S, Mosele JI, Pizarro N, et al. Effect of virgin olive oil and thyme phenolic compounds on blood lipid profile: implications of human gut microbiota. Eur J Nutr. 2015. Published online 2016 Nov 5. DOI:10.1007/s00394-015-1063-2
  • Mosele JI, Martín-Peláez S, Macià A, et al. Faecal microbial metabolism of olive oil phenolic compounds: in vitro and in vivo approaches. Mol Nutr Food Res. 2014;58:1809–1819.
  • Markopoulos C, Vertzoni M, Agalias A, et al. Stability of oleuropein in the human proximal gut. Pharm Pharmacol. 2009;61:143–149.
  • Bazoti FN, Gikas E, Tsarbopoulos A. Simultaneous quantification of oleuropein and its metabolites in rat plasma by liquid chromatography electrospray ionization tandem mass spectrometry. Biomed Chrom. 2010;24:506–515.
  • Vissers MN, Zock PL, Roodenburg AJC, et al. Olive oil phenols are absorbed in humans. J Nutr. 2002;132:409–417.
  • De Bock M, Thorstensen EB, Derraik JGB, et al. Human absorption and metabolism of oleuropein and hydroxytyrosol ingested as olive (Olea europaea L.) leaf extract. Mol Nutr Food Res. 2013;57:2079–2085.
  • Garcia-Villalba R, Larrosa M, Possemiers S, et al. Bioavailability of phenolics from an oleuropein-rich olive (Olea europaea) leaf extract and its acute effect on plasma antioxidant status: comparison between pre- and postmenopausal women. Eur J Nutr. 2014;53:1015–1027.
  • Serra A, Rubiò L, Borràs X, et al. Distribution of olive oil phenolic compounds in rat tissues after administration of a phenolic extract from olive cake. Mol Nutr Food Res. 2012;56:486–496.
  • Quirantes-Piné R, Zurek G, Barrajòn-Catalàn E, et al. A metabolite-profiling approach to assess the uptake and metabolism of phenolic compounds from olive leaves in SKBR3 cells by HPLC-ESI-QTOF-MS. J Pharm Biomed Anal. 2013;72:121–126.
  • Turner RS, Thomas RG, Craft S, et al. Alzheimer’s Disease Cooperative Study. A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease. Neurology. 2015;85:1383–1391.
  • Ringman JM, Frautschy SA, Teng E, et al. Oral curcumin for Alzheimer’s disease: tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study. Alzheimers Res Ther. 2012;4:43.
  • Cheng KK, Yeung CF, Ho SW, et al. Highly stabilized curcumin nanoparticles tested in an in vitro blood-brain barrier model and in Alzheimer’s disease Tg2576 mice. The AAPS J. 2013;15:324–336.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.